Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Cocaine vaccine nearing clinic

Nov. 8, 1996

New therapeutic for smoking cessation to enter pivotal trials

Oct. 25, 1996

Nicotine inhaler for smoking cessation: Clinical trial results

Oct. 25, 1996

Cangene acquires iron chelator from Apotex

Oct. 18, 1996

Japanese scientists discover potential agent for siderosis

Oct. 11, 1996

Cocaine vaccine proven effective in animal model

Oct. 11, 1996

First launch for inhaled smoking cessation product

Sep. 13, 1996

Known antipsychotic claimed for drug dependence

Sep. 13, 1996

Nicotine nasal spray codevelopment agreement

Aug. 23, 1996

ImmuLogic receives SBIR grant for cocaine vaccine research

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Beone eyes Huahui Health’s trispecific HH-160 with $2B option deal
BioWorld
Beone Medicines Ltd. gained an exclusive option to develop cancer immunotherapy HH-160 worldwide in a deal potentially worth more than $2 billion for Huahui...
Unique trial strategy muddies the ODAC waters for camizestrant
BioWorld
Following a discussion that focused more on a new personalized trial strategy rather than the proposed therapy, the U.S. FDA’s Oncologic Drugs Advisory Committee...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...